Product Details
| Product Name: Retatrutide | CAS No.: 2381089-83-2 |
| Min. Order: 100mg | Purity: 99% HPLC |
| Supply Ability: 20kg | Release date: 2025/07/25 |
Retatrutide is an experimental drug for obesity developed by American pharmaceutical company Eli Lilly and Company. It is a triple hormone receptor agonist of GLP-1, GIP, and GCGR receptors. It has been shown to achieve a more than 24% mean weight reduction in non-diabetic obese or overweight adults during a phase 2 trial.
Company Profile Introduction
We are a company focusing on chemical products.
We can provide injection grade of peptides ( semaglutide,tirzepatide,Retatrutide HGH TB500 etc.)
Our guarantee:
Accurate content, no shortage. If shortage, refund!
High purity and reliable quality. If there are quality issues or purity below 98%, refund!
100% delivery. Customs detained and lost during transportation, resend！
We support PayPal commercial payments and provide protection for buyers
Expect your reply soon.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $247.00/1mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-12-03 | |
| $5.00/1Gram |
VIP1Y
|
Wuhan JiyunZen Tech Co., Ltd.
|
2025-11-18 | |
| $70.00/1box |
VIP1Y
|
Hainan Fubai Trading Co., LTD
|
2025-11-06 | |
| $80.00/1Box |
VIP1Y
|
GUANGZHOU SHENGYOU IM&EX CO,.LTD
|
2025-09-28 | |
| $75.00/1Box |
VIP1Y
|
Hebei Kenwei Packaging Products Co., LTD
|
2025-09-26 | |
| $0.00/1box |
VIP1Y
|
Shanghai Yimeixin Technology Co., LTD
|
2025-09-24 | |
| $0.00/25kg |
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-09-18 | |
| $85.00/1boxbox |
VIP1Y
|
Hebei Lutong Import and Export Co., Ltd
|
2025-09-18 | |
| $0.00/1kg |
VIP2Y
|
Shandong Hanjiang Chemical Co., Ltd
|
2025-09-10 | |
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2025-09-10 |
China